XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Schedule of Segment Perfomance Measures by Segment) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Segment Reporting Information [Line Items]    
Net sales $ 111,748 $ 101,317
Gross profit 21,505 18,519
Income (loss) before income taxes 7,622 4,739
Human Health[Member]
   
Segment Reporting Information [Line Items]    
Net sales 26,409 22,753
Gross profit 8,103 6,591
Income (loss) before income taxes 3,119 2,551
Pharmaceutical Ingredients[Member]
   
Segment Reporting Information [Line Items]    
Net sales 40,608 42,309
Gross profit 6,576 6,772
Income (loss) before income taxes 2,553 2,880
Performance Chemicals[Member]
   
Segment Reporting Information [Line Items]    
Net sales 44,731 36,255
Gross profit 6,826 5,156
Income (loss) before income taxes 3,085 1,590
Unallocated Corporate [Member]
   
Segment Reporting Information [Line Items]    
Income (loss) before income taxes $ (1,135) $ (2,282)